National Healthcare
119 hedge funds and large institutions have $349M invested in National Healthcare in 2017 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 51 increasing their positions, 35 reducing their positions, and 7 closing their positions.
114% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 7
111% more call options, than puts
Call options by funds: $2.38M | Put options by funds: $1.13M
46% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 35
7% more funds holding
Funds holding: 111 → 119 (+8)
0.39% more ownership
Funds ownership: 37.26% → 37.65% (+0.39%)
2% less capital invested
Capital invested by funds: $354M → $349M (-$5.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$2.32M |
| 2 |
TCIM
TIAA CREF Investment Management
New York
|
+$1.3M |
| 3 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$1.24M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.16M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.02M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$9.37M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.42M |
| 3 |
LSV Asset Management
Chicago,
Illinois
|
-$926K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$894K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$676K |
NHC Hedge Fund Activity: Q4 2017 in Review
119 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in National Healthcare (NHC) for Q4 2017, worth a combined $349M — down 1.6% from $354M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new NHC positions and 7 closed out — a net gain of 8 holders — while 51 added to existing stakes and 35 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $2.32M. The largest seller was T. Rowe Price Associates, cutting an estimated $9.37M.
- 119 institutional investors held National Healthcare (NHC) as of Q4 2017, up from 111 in Q3 2017.
- Funds reported $349M of National Healthcare stock for Q4 2017, down 1.6% quarter-over-quarter.
- 15 funds opened new National Healthcare positions in Q4 2017 and 7 closed out, a net change of +8 holders.
- The largest National Healthcare buyer in Q4 2017 was Renaissance Technologies, an estimated $2.32M added.
- The largest National Healthcare seller in Q4 2017 was T. Rowe Price Associates, an estimated $9.37M sold.
Based on aggregated 13F filings for Q4 2017.